Two lots of antibiotics manufactured in India
are being recalled for not meeting quality standards, according to documents
recently issued by the Department of Drug Management under the Ministry of
Health.
The two
drugs are Ceferaxim 125 (Cefuroxime 125mg), lot no. 173316001, with the expiry
date of January 5, 2018 and registration No.VN-11733-11, manufactured by
Vintanova Pharma Pvt. Ltd., and imported by Dai Nam Pharmaceutical Co. Ltd.,
and Rom-150 tablets (Roxithromycin 150mg), lot No.ZET1709, manufacturing date
July 22, 2014 and expiry date July 21, 2017 with registration No.VN-17178-13
manufactured by Zee Laboratories and imported by Codupha Central Pharmaceutical
JSC.
A lot of
antibiotics manufactured in Vietnam was also asked to be recalled, namely
Philtadol (Cefpodoxim 100mg), lot No.15002, with the expiry date of November 3,
2017, registration No.VD-22044-14, produced by Korean company Phil Inter Pharma
at its Vietnamese plant in Vietnam-Singapore industrial park in the southern
province of Binh Duong.
The
decision to recall these drugs was based on tests performed by the National
Institute of Drug Quality Control.
India is
one of the world’s major suppliers of pharmaceutical products and ingredients
and the second largest supplier of these items in Vietnam, after France.
According
to data released by the department, at the moment, there are 7,630 valid drug
registration numbers in Vietnam, of which 2,814 were patented by Indian
companies.
Besides,
200 of the 718 foreign manufacturers of drugs and drug ingredients licensed to
operate in Vietnam are Indian.
The
preferential tariffs stipulated by a free trade agreement signed by India with
the ASEAN, of which Vietnam is a member, have facilitated the import of Indian
medicines to the country.
However,
despite making up for a significant share of the market, drugs imported from
India have a bad track record. In the recalls ordered by the department from
2011 to now, the majority of the drugs in question were manufactured in India.
Last
November, the Ministry of Health requested to get rid of all Cefpodoxime
Proxetil Tablets USP manufactured by Indian Syncom Formulation due to low
quality.
Last
month, the department recalled Efixime 100DT, lot No.FNB-07, manufacturing date
September 26, 2014, expiry date September 25, 2017, and registration
No.VN-4941-10, manufactured by Indian All Serve Healthcare Pvt., Ltd., and
imported by Sohaco Trading and Pharmaceutical Group JSC, also due to low
quality.
VIR
No comments:
Post a Comment